Semenogelin I (SEMG1) (Middle Region) Peptid
SEMG1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle SEMG1 Produkte
- SEMG1 (Semenogelin I (SEMG1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SEMG1 antibody (Catalog #: ARP42089_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SEMG1 (Semenogelin I (SEMG1))
- Hintergrund
-
SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly
Alias Symbols: MGC14719, SEMG, SGI, CT103, dJ172H20.2
Protein Interaction Partner: KLK2,KLK3,PRKCA,SEMG2,TGM1,UBQLN4,SEMG2
Protein Size: 402 - Molekulargewicht
- 40 kDa
- Gen-ID
- 6406
- NCBI Accession
- NM_198139, NP_937782
-
Sie sind hier:
